Wegovy Approved By FDA to Reduce Heart Attack Risk - The New York Times
- Wegovy Approved By FDA to Reduce Heart Attack Risk The New York Times
- Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug Fox Business
- Novo Nordisk's Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage CNBC
- Novo's obesity superstar Wegovy wins FDA nod to cut cardio risks in key label expansion FiercePharma
- FDA Approves Wegovy For Heart Conditions in Game-Changing Move ScienceAlert